These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9507122)

  • 41. CCK receptor activation may prevent tolerance to morphine in mice.
    Rezayat M; Nikfar S; Zarrindast MR
    Eur J Pharmacol; 1994 Mar; 254(1-2):21-6. PubMed ID: 8206114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat.
    Mönnikes H; Lauer G; Arnold R
    Brain Res; 1997 Oct; 770(1-2):277-88. PubMed ID: 9372230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
    Pu SF; Zhuang HX; Han JS
    Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
    Russell JA; Coombes JE; Leng G; Bicknell RJ
    J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry.
    Ingram SM; Krause RG; Baldino F; Skeen LC; Lewis ME
    J Comp Neurol; 1989 Sep; 287(2):260-72. PubMed ID: 2794128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia.
    Broberger C; Holmberg K; Shi TJ; Dockray G; Hökfelt T
    Brain Res; 2001 Jun; 903(1-2):128-40. PubMed ID: 11382396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The excitatory effect of systemic cholecystokinin on oxytocin neurones is unchanged by morphine dependence and withdrawal.
    Murphy NP; Brown CH; Leng G; Russell JA
    Adv Exp Med Biol; 1995; 395():207-8. PubMed ID: 8713969
    [No Abstract]   [Full Text] [Related]  

  • 49. Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1086-92. PubMed ID: 1545380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES; McQuade J; Moran TH; Smith GP
    Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin.
    Panerai AE; Rovati LC; Cocco E; Sacerdote P; Mantegazza P
    Brain Res; 1987 Apr; 410(1):52-60. PubMed ID: 3580899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.
    Stanfa LC; Dickenson AH
    Br J Pharmacol; 1993 Apr; 108(4):967-73. PubMed ID: 8485635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A locus and mechanism of action for associative morphine tolerance.
    Mitchell JM; Basbaum AI; Fields HL
    Nat Neurosci; 2000 Jan; 3(1):47-53. PubMed ID: 10607394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus.
    Holmes PV; de Bartolomeis A; Koprivica V; Crawley JN
    Synapse; 1995 Mar; 19(3):197-205. PubMed ID: 7540319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CCK, bombesin, and carbachol stimulate c-fos, c-jun, and c-myc oncogene expression in rat pancreatic acini.
    Lu L; Logsdon CD
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G327-32. PubMed ID: 1415544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential basal proenkephalin gene expression in dorsal striatum and nucleus accumbens, and vulnerability to morphine self-administration in Fischer 344 and Lewis rats.
    Martín S; Manzanares J; Corchero J; García-Lecumberri C; Crespo JA; Fuentes JA; Ambrosio E
    Brain Res; 1999 Mar; 821(2):350-5. PubMed ID: 10064821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative analysis of the central CCK system in Fawn Hooded and Wistar Kyoto rats: extended localisation of CCK-A receptors throughout the rat brain using a novel radioligand.
    Lodge DJ; Lawrence AJ
    Regul Pept; 2001 Jun; 99(2-3):191-201. PubMed ID: 11384782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholecystokinin octapeptide alters morphine-induced effects on EEG power spectra both quantitatively and qualitatively.
    Hudson GM; Marquis KL; Stamidis H; Young GA
    Eur J Pharmacol; 1992 Oct; 221(2-3):217-22. PubMed ID: 1426001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increases of CCK mRNA and peptide in different brain areas following acute and chronic administration of morphine.
    Ding XZ; Bayer BM
    Brain Res; 1993 Oct; 625(1):139-44. PubMed ID: 8242392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.